While this is the first study to report this specific target protein in TNBC, NFKBIA has been implicated within the mechanism of selinexor sensitivity for other cancer contexts, such as non-Hodgkin lymphoma, MM and high-grade glioma [17,37,40,42,43]. The gene discussed is NFKBIA; the disease is central nervous system cancer.